4.5 Article

Induction of Endogenous Antibody Recruitment to the Surface of the Pathogen Enterococcus faecium

期刊

ACS INFECTIOUS DISEASES
卷 7, 期 5, 页码 1116-1125

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.0c00547

关键词

Enterococcus faecium; vancomycin-resistant enterococci; peptidoglycan; stem peptide mimic

资金

  1. NIH [GM124893-01]

向作者/读者索取更多资源

Conventional small molecule antibiotics will continue to be the main treatment option in the foreseeable future, but a growing number of patients are not responding to them, indicating the need for nontraditional therapies. By grafting immunogenic agents onto bacterial cell surfaces, the immune system can be re-engaged to combat pathogenic bacteria effectively.
For the foreseeable future, conventional small molecule antibiotics will continue to be the predominant treatment option due to wide patient coverage and low costs. Today, however, there is already a significant portion of patients that fail to respond to small molecule antibiotics and, according to the Centers for Disease Control and Prevention, this number is poised to increase in the coming years. Therefore, this rise in drug resistant bacteria must be countered with the development of nontraditional therapies. We propose a measure based on the re-engagement of the immune system toward pathogenic bacteria by grafting bacterial cell surfaces with immunogenic agents. Herein, we describe a class of cell wall analogues that selectively graft bacterial cell surfaces with epitopes that promote their opsonization. More specifically, synthetic analogues of peptidoglycan conjugated to haptens were designed to be incorporated by the cell wall biosynthetic machinery into live Enterococcus faecium. E. faecium is a formidable human pathogen that poses a considerable burden to healthcare and often results in fatalities. We showed that treatment of E. faecium and vancomycin-resistant strains with the cell wall analogues led to the display of haptens on the cell surface, which induced the recruitment of antibodies existing in the serum of humans. These results demonstrate the feasibility in using cell wall analogues as the basis of a class of bacterial immunotherapies against dangerous pathogens.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据